Vanda Pharmaceuticals Inc. ( VNDA) - Key Metrics
VNDA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.97 | -$2.39 | -$0.50 | -$0.50 |
| 2025Q3 | $0.96 | -$0.38 | -$0.54 | -$0.54 |
| 2025Q2 | $0.89 | -$0.46 | -$0.26 | -$0.26 |
| 2025Q1 | $0.85 | -$0.50 | -$0.57 | -$0.57 |
VNDA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -0.92 |
| 2025Q3 | ? | -3.25 |
| 2025Q2 | ? | -2.56 |
| 2025Q1 | ? | -2.28 |
VNDA
Price: $5.73
52 week price:
Earnings Per Share: -4.06 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 456204
Ebitda: -1.4 millionMarket Capitalization: 366.2 million